227 related articles for article (PubMed ID: 23982256)
41. Risk-reducing mastectomy for BRCA gene mutation carriers.
Euhus DM
Ann Surg Oncol; 2015 Sep; 22(9):2807-9. PubMed ID: 25821000
[No Abstract] [Full Text] [Related]
42. Breast cancer following ovarian cancer in BRCA mutation carriers.
Gangi A; Cass I; Paik D; Barmparas G; Karlan B; Dang C; Li A; Walsh C; Rimel BJ; Amersi FF
JAMA Surg; 2014 Dec; 149(12):1306-13. PubMed ID: 25372568
[TBL] [Abstract][Full Text] [Related]
43. Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers.
Metcalfe K; Lynch HT; Ghadirian P; Tung N; Kim-Sing C; Olopade OI; Domchek S; Eisen A; Foulkes WD; Rosen B; Vesprini D; Sun P; Narod SA
Breast Cancer Res Treat; 2011 May; 127(1):287-96. PubMed ID: 21221768
[TBL] [Abstract][Full Text] [Related]
44. Breast-conserving surgery in BRCA1/2 mutation carriers: are we approaching an answer?
Garcia-Etienne CA; Barile M; Gentilini OD; Botteri E; Rotmensz N; Sagona A; Farante G; Galimberti V; Luini A; Veronesi P; Bonanni B
Ann Surg Oncol; 2009 Dec; 16(12):3380-7. PubMed ID: 19649554
[TBL] [Abstract][Full Text] [Related]
45. ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers.
Adem C; Soderberg CL; Hafner K; Reynolds C; Slezak JM; Sinclair CS; Sellers TA; Schaid DJ; Couch F; Hartmann LC; Jenkins RB
Genes Chromosomes Cancer; 2004 Sep; 41(1):1-11. PubMed ID: 15236312
[TBL] [Abstract][Full Text] [Related]
46. Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.
de Alcantara Filho P; Capko D; Barry JM; Morrow M; Pusic A; Sacchini VS
Ann Surg Oncol; 2011 Oct; 18(11):3117-22. PubMed ID: 21847697
[TBL] [Abstract][Full Text] [Related]
47. MRI volumetric analysis of breast fibroglandular tissue to assess risk of the spared nipple in BRCA1 and BRCA2 mutation carriers.
Baltzer HL; Alonzo-Proulx O; Mainprize JG; Yaffe MJ; Metcalfe KA; Narod SA; Warner E; Semple JL
Ann Surg Oncol; 2014 May; 21(5):1583-8. PubMed ID: 24526546
[TBL] [Abstract][Full Text] [Related]
48. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
[TBL] [Abstract][Full Text] [Related]
49. Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin.
Kwa M; Edwards S; Downey A; Reich E; Wallach R; Curtin J; Muggia F
Ann Surg Oncol; 2014 May; 21(5):1468-73. PubMed ID: 24081797
[TBL] [Abstract][Full Text] [Related]
50. Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.
Cibula D; Zikan M; Dusek L; Majek O
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1197-207. PubMed ID: 21916573
[TBL] [Abstract][Full Text] [Related]
51. Approaches to microvascular breast reconstruction after total skin-sparing mastectomy: a comparison of techniques.
Raghavan S; Peled AW; Hansen SL; Esserman LJ; Sbitany H
Ann Plast Surg; 2015 May; 74 Suppl 1():S46-51. PubMed ID: 25875911
[TBL] [Abstract][Full Text] [Related]
52. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
Fatouros M; Baltoyiannis G; Roukos DH
Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
[TBL] [Abstract][Full Text] [Related]
53. Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.
Mislowsky A; Domchek S; Stroede C; Bergey MR; Sonnad SS; Wu L; Tchou J
Ann Surg Oncol; 2011 Mar; 18(3):745-51. PubMed ID: 20972632
[TBL] [Abstract][Full Text] [Related]
54. International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers.
Semple J; Metcalfe KA; Lynch HT; Kim-Sing C; Senter L; Pal T; Ainsworth P; Lubinski J; Tung N; Eng C; Gilchrist D; Blum J; Neuhausen SL; Singer CF; Ghadirian P; Sun P; Narod SA;
Ann Surg Oncol; 2013 Nov; 20(12):3817-22. PubMed ID: 23740344
[TBL] [Abstract][Full Text] [Related]
55. Breast cancer size estimation with MRI in BRCA mutation carriers and other high risk patients.
Mann RM; Bult P; van Laarhoven HW; Span PN; Schlooz M; Veltman J; Hoogerbrugge N
Eur J Radiol; 2013 Sep; 82(9):1416-22. PubMed ID: 23567481
[TBL] [Abstract][Full Text] [Related]
56. [Breast reconstruction after skin-sparing mastectomy or nipple-sparing mastectomy for breast cancer].
Chen J; Lü Q; Wang X; Li H; Chen Y; Yang X; Zeng H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):872-5. PubMed ID: 24063181
[TBL] [Abstract][Full Text] [Related]
57. Oncologic Trends, Outcomes, and Risk Factors for Locoregional Recurrence: An Analysis of Tumor-to-Nipple Distance and Critical Factors in Therapeutic Nipple-Sparing Mastectomy.
Frey JD; Salibian AA; Lee J; Harris K; Axelrod DM; Guth AA; Shapiro RL; Schnabel FR; Karp NS; Choi M
Plast Reconstr Surg; 2019 Jun; 143(6):1575-1585. PubMed ID: 30907805
[TBL] [Abstract][Full Text] [Related]
58. Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.
Grinstein O; Krug B; Hellmic M; Siedek F; Malter W; Burke C; Schmutzler R; Maintz D; Rhiem K
Surg Oncol; 2019 Jun; 29():126-133. PubMed ID: 31196476
[TBL] [Abstract][Full Text] [Related]
59. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
[TBL] [Abstract][Full Text] [Related]
60. Skin-sparing mastectomy with immediate breast reconstruction: a critical analysis of local recurrence.
Rivadeneira DE; Simmons RM; Fish SK; Gayle L; La Trenta GS; Swistel A; Osborne MP
Cancer J; 2000; 6(5):331-5. PubMed ID: 11079173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
